메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson's and First Enrollment in China's Randomized MSA Trial for NouvNeu004

CHENGDU, China, Feb. 23, 2026 -- The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical stages in the U.S. and China. Concurrently, the company's "AI + Chemical Induction" platform saw its first U.S. patient dosed for Parkinson's disease at Weill Cornell Medical Center and its first patient enrolled for Multiple System Atrophy (MSA) at Beijing Tiantan Hospital. These parallel milestones for NouvNeu001 and NouvNeu004 represent the next phase of iRegene's global strategy, transitioning from
- 김갑성 기자
- 2026-02-23 21:00
Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

TAIPEI, Feb. 23, 2026 -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals Pty Ltd. ("Arrotex"), for exclusive rights to the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), an innovative topical eyedrop for the treatment of inflammation and pain following ocular surgery in Australia and New Zealand. Arrotex, 'Australia's Medicines Company', currently fulfills 50% of the country's total volume and is a leader in
- 김갑성 기자
- 2026-02-23 14:00
Herbalife Announces Cristiano Ronaldo Invests $7.5 Million in Pro2col™ Technology, Acquires 10% Equity Stake

Long-time partner invests in shared vision for personalized health and wellness HONG KONG, Feb. 23, 2026 -- Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, announced global sports icon Cristiano Ronaldo acquired a 10% equity interest in HBL Pro2col Software, LLC, an indirect wholly-owned subsidiary of Herbalife that holds the Pro2col technology. Pro2col is Herbalife's next-generation, digital, personalized health and wellness operating system, designed to drive daily engagement, sustainable behavior change, and measurable outcomes thro
- 김갑성 기자
- 2026-02-23 12:00
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation

BANGKOK, Feb. 23, 2026 -- With a remarkable 30% growth in size and participation, Vitafoods Asia 2026 organised by Informa Markets, is set to redefine the nutraceutical industry in Asia, offering unparalleled opportunities for innovation and collaboration. The event will feature an exhibit space of 30,000 square meters with over 800 companies, representing an impressive 30% growth compared to the 2025 edition. Taking place once again at the state-of-the-art venue in Bangkok – Queen Sirikit National Convention Center (QSNCC) from 2 – 4 September 2026. New Country Pavilio
- 김갑성 기자
- 2026-02-23 10:09
CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC

[ 메디채널 김갑성 기자 ] Following approval by the European Commission (EC), sugemalimab has received a new indication approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for stage III non-small cell lung cancer (NSCLC). This marks the second indication approved for the product in the UK. This approval is based on the GEMSTONE-301 study, a multicenter, randomized, double-blind Phase III trial. Results demonstrated that sugemalimab provided statistically significant improvement in progression-free survival (PFS) and a clinically meaningful prolongation of overall survival
- 김갑성 기자
- 2026-02-23 08:10
HeyGears Announces One-Piece Denture Solution - Redefining Digital Dentures with Dual-Material 3D Printing

[ 메디채널 김갑성 기자 ] HeyGears' One-Piece Denture Solution enables dual-material denture DLP 3D printing, seamlessly fusing denture base and teeth materials in a single printing process to deliver more natural aesthetics and a comfortable fit. CHICAGO, Feb. 20, 2026 -- HeyGears announces breakthrough One-Piece Denture Solution at LMT LAB DAY Chicago. [ 메디채널 김갑성 기자 ] HeyGears' One-Piece Denture Solution breaks through the technological constraints and experiential barriers of traditional denture manufacturing by deeply integrating HeyGears' new UltraCraft MMF (Mu
- 김갑성 기자
- 2026-02-20 22:00
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the year ended December 31, 2025. FY 2025 key results1 Group performance2: Double-digit revenue growth and positive adjusted operating cash flow Revenue of US$803.8 million, up by 56%3 and achieving upsized full year guidance4. US$157.1 million invested in research and development (R&D) product development for late-stage therapeutics and precision medicine pipeline assets5,
- 김갑성 기자
- 2026-02-20 07:27
Indian, Regional, and Global Partners Launch Initiatives to Address Extreme Heat in South Asia

[ 메디채널 김갑성 기자 ] The World Health Organization (WHO)–World Meteorological Organization (WMO) Climate and Health Joint Programme, The Rockefeller Foundation, and Wellcome announce new regional efforts to connect climate science to health action to prevent heat impacts, help communities flourish, and save lives. MUMBAI, India, Feb. 20, 2026 -- At Mumbai Climate Week, the WHO-WMO Climate and Health Joint Programme, The Rockefeller Foundation, and Wellcome announced two new integrated initiatives to protect South Asians from extreme heat – a rapidly escalating threat to human health and e
- 김갑성 기자
- 2026-02-20 04:56
TraceLink Named to RXinsider's 2026 Pharmacy500 for Powering Digital Network Orchestration Across the Regulated Pharmacy Supply Chain

The recognition highlights TraceLink's Business-to-Network Integrate-Once™ platform that enables end-to-end digitalization, interoperable compliance execution, and operational resilience at industry scale Summary TraceLink is recognized for delivering a unified, network-based platform that helps pharmacies and their trading partners orchestrate procure-to-pay through an Integrate-Once™ model, automate the identification and reconciliation of recalled products, and operationalize DSCSA regulatory requirements on an industrial-grade foundation designed for mission-critical, regula
- 김갑성 기자
- 2026-02-19 23:00
BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market

XI'AN, China, Feb. 19, 2026 -- Bon Natural Life Limited (Nasdaq: BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, today announced the successful development of a premium anti-aging facial mask incorporating apple polyphenols as its core active ingredient and integrated with AI-enabled flexible bio-electronic technology. Leveraging advanced transdermal delivery systems, this product integrates plant-derived active ingredients with intelligent flexible electronics, creating a next-generation s
- 김갑성 기자
- 2026-02-19 22:00

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 02일 23시 00분